Panatuss PED description, usages, side effects, indications, overdosage, supplying and lots more!

Panatuss PED

Seyer Pharmatec, Inc.

  • Description
  • Clinical Pharmacology
  • Indications & Usage
  • Contraindications
  • Warnings
  • Precautions
  • Side Effects
  • Overdosage
  • Dosage & Administration
  • How Supplied
  • Patient Counseling Information
  • Supplemental Patient Material
  • Boxed Warning
  • Patient Package Insert
Drug Facts



FULL PRESCRIBING INFORMATION

Active ingredient

Active Ingredients                         Purpose
(in each 1 mL)

Chlophedianol HCl 6.25 mg ...................... Cough Suppressant

Dexchlorpheniramine Maleate 0.5 mg ......... Antihistamine

Pseudoephedrine HCl 15 mg ................... Nasal Decongestant

Purpose

Purpose

Cough Suppressant

Antihistamine

Nasal Decongestant

Uses

Uses

Temporarily calms cough due to minor throat and bronchial irritation as may occur with the common cold

  • calms the cough control center and relieves coughing
  • non narcotic cough suppressant for the temporary relief of cough
  • temporarily relieves runny nose and alleviates sneezing, itching of the nose or throat and itchy, watery eyes due to hay fever or other upper respiratory allergies
  • temporarily relieves nasal congestion due to the common cold
  • helps decongest sinus openings and passages; temporarily relieves sinus congestion and pressure

Warnings

  • do not exceed recommended dosage
  • a persistent cough may be sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash or persistent headache, consult a doctor
Ask a doctor before use if a child has
  • a persistent or chronic cough such as occurs with asthma, chronic bronchitis, or emphysema, or where cough is accompanied by excessive phlegm (mucus) unless directed by a doctor
  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes
  • glaucoma
Ask a doctor before use if a child is taking sedatives or tranquilizers.

When using this product

  • excitability may occur, especially in children
  • may cause marked drowsiness
  • sedatives and tranquilizers may increase the drowsiness effect

Do not use

  • in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child's prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product
Stop use and ask a doctor if
  • nervousness, dizziness or sleeplessness occur
  • if symptoms do not improve within 7 days or are accompanied by fever, rash or persistent headache.

Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center immediately.

Directions

  • take every 6 hours, not to exceed 4 doses in 24 hours or as directed by a physician

Children 6 to under 12 years of age
2 mL
Children 2 to under 6 years of age
Ask a doctor
Children under 2 years of age
Ask a doctor

Inactive ingredients

Citric acid, flavor, methylparaben, potassium citrate, potassium sorbate, propylparaben, propylene glycol, purified water, sorbitol, sucralose, xanthan gum

Questions or comments?1-888-782-3585

Panatuss PED

Chlophedianol Hydrchloride, Dexchlorpheniramine Maleate, Pseudoephedrine Hydrochloride SOLUTION/ DROPS

Product Information

Product Type Human otc drug label Item Code (Source) NDC:11026-2785
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Chlophedianol Hydrochloride Chlophedianol 6.25 mg
Dexchlorpheniramine Maleate DEXCHLORPHENIRAMINE 0.5 mg
Pseudoephedrine Hydrochloride Pseudoephedrine 15 mg

Inactive Ingredients

Ingredient Name Strength
CITRIC ACID MONOHYDRATE
METHYLPARABEN
POTASSIUM CITRATE
POTASSIUM SORBATE
PROPYLPARABEN
propylene glycol
water
sorbitol
Sucralose
XANTHAN GUM

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 60 in 1 BOTTLE, DROPPER
2 NDC:11026-2785-2 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part341 2012-12-15


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.